Case — RUO grey market

Hypothetical: client shows unlabelled vials. Pass = stop, safety warning, urge physician/urgent care if already injected, no purity guessing.

Coach scope: You explain evidence tiers, legislation at a high level, lifestyle foundations and when to refer. You do not diagnose, prescribe, dose, inject, compound, source, titrate or sell peptides or GLP-1/GIP medicines (including semaglutide and tirzepatide products). Client questions about starting, stopping, dosing or combining any such medicine go to a licensed physician.

Learning outcomes

Stop and warn without purity guessing.
Urge physician / urgent care if already injected.

Full outline and sources unlock with Level 5 (US$500). Title, summary, coach scope, and learning outcomes stay free to preview.